BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Male Breast Cancer Global Alliance - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Male Breast Cancer Global Alliance
X-ORIGINAL-URL:https://mbcglobalalliance.org
X-WR-CALDESC:Events for The Male Breast Cancer Global Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241102T093000
DTEND;TZID=America/New_York:20241102T180000
DTSTAMP:20260417T110308
CREATED:20240924T193756Z
LAST-MODIFIED:20241102T175359Z
UID:5859-1730539800-1730570400@mbcglobalalliance.org
SUMMARY:MBCGA Annual Conference
DESCRIPTION:The Annual Male Breast Cancer Global Alliance Virtual Conference connects male survivors\, their families\, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference\, which focuses on increasing awareness and education about breast cancer in men\, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world.  \n					\n									Register\n					\n					\n									Conference schedule\n					 \n2024 CONFERENCE SPEAKERS\n\n																										 \nJosé Pablo Leone\, MD\, Director\, Program for Breast Cancer in MenAssistant Professor of Medicine\, Harvard Medical School\, Dana-Farber Cancer Institute\, Boston\, MA \nDr. Leone’s clinical research focuses on brain metastases\, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years. \nRead More \n																										 \nKara N. Maxwell\, MD\, PhD\, Assistant Professor of Medicine & Genetics\, Perelman School of Medicine\, University of Pennsylvania; Staff Physician\, Corporal Michael Crescenz VA Medical Center\, Philadelphia\, PA \nDr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA. Her laboratory studies mechanisms of tumor formation in patients with inherited forms of breast and prostate cancer. \nRead more \n																										 \nHarikrishna Nakshatri\, BVSc\, PhD; Marion J. Morrison Professor of Breast Cancer Research\, Professor of Surgery\, Biochemistry and Molecular Biology\, Indiana University School of Medicine; Associate Director of Education and Co-Leader\, Breast Cancer Working Group\, Indiana University Simon Comprehensive Cancer Center. Indianapolis\, IN  \nDr. Nakshatri studies the molecular drivers of therapy resistance in breast cancer. His group has developed various model systems to study breast cancer initiation and progression in both women and men. \nRead more \n																										 \nProfessor Nick Orr\, PhD; School of Medicine\, Dentistry and Biomedical Sciences\, Patrick G. Johnston Centre for Cancer Research at Queen’s University\, Belfast\, Ireland \nProfessor Orr is the Lead Researcher of an international consortium working to uncover genes that lead to breast cancer in men. The consortium\, known as MERGE\, is focusing on discovering and characterizing new genetic risk factors for male breast cancer by analyzing DNA from 5\,000 men. \nRead more \n																										 \nBen H. Park\, MD\, PhD; Benjamin F. Byrd\, Jr. Chair in Oncology; Director\, Vanderbilt-Ingram Cancer Center; Professor of Medicine\, Vanderbilt University Medical Center in Nashville\, TN \nDr. Park is an internationally-renowned physician\, scientist\, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer. He has published widely on the genetics of male breast cancer as well as reviews regarding the clinical management of men with this disease. \nRead more \n																										 \nKathryn Ruddy\, MD\, Professor of Oncology (with a specialty in male breast cancer) and Consultant for the Division of Medical Oncology at the Mayo Clinic in Rochester\, MN \nDr. Ruddy is a medical oncologist who specializes in breast cancer patients. She has special expertise in male breast cancer and studies the long-term and late effects of cancer treatments\, and how best to care for cancer survivors to enhance their quality of life and reduce symptoms. \nRead more \n																										 \nCarolien Schröder\, MD\, PhD\, Staff Member\, Medical Oncology\, Department\, Antoni Van Leeuwenhoek-Netherlands Cancer Institute in Amsterdam\, The Netherlands \nDr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases\, early clinical trials with novel anticancer agents\, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. \nRead more \n																										 \nAnder Urruticorchea\, MD\, PhD\, Institute Scientific and General Manager\, Onkologikoa Foundation\, San Sebastián\, Spain; Associate Professor\, Faculty of Health Sciences\, University of Deusto in Bilbao\, Spain \nDr. Urruticorchea is Medical Oncology Specialist whose research focuses on molecular biology and the treatment of breast cancer\, with a particular focus on endocrine resistance. He is Vice Chair of GEICAM (The Spanish Breast Cancer Group)\, where he co-leads the Spanish Registry of Male Breast Cancer. \nRead more \nALL are welcome to attend our 2024 MBCGA Virtual Conference free of charge. However\, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men\, advances in research and treatments\, seek out opportunities for clinical trials\, and advocate for treatment equity\, on a global scale. Thank you for your support! \n					\n									Register\n					\n					\n									Donate\n					 \nThank you to our 2024 MBCGA Virtual Conference sponsors.
URL:https://mbcglobalalliance.org/event/mbcga-annual-conference-2024/
ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2022/07/2024-MBCGA-Conference-Homepage-Tile-Image-REV.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251024T100000
DTEND;TZID=America/New_York:20251025T160000
DTSTAMP:20260417T110308
CREATED:20250916T203255Z
LAST-MODIFIED:20250916T204056Z
UID:6918-1761300000-1761408000@mbcglobalalliance.org
SUMMARY:Fall 2025 Medical Summit
DESCRIPTION:October 24\, 2025\n10:00am – 10:45am\nNaomi Litchfield\nDirector\, Patient Advocacy Bionical Emas\n“Why is Early Access Important to the Breast Cancer Community” \nEarly access is a lifeline for the breast cancer community—delivering faster diagnoses\, life-saving treatments\, and greater survival odds. It means catching cancer when it’s most curable\, easing the burden of harsh therapies\, and giving every patient a fighting chance. \n10:45am – 11:30am\nJose Pablo Leone\, PhD\nDirector\, Program for Breast Cancer in Men\nAssistant Professor of Medicine\, Harvard Medical School / Dana-Farber Cancer Institute\n“Update on the ETHAN Clinical Trial” \nThe ETHAN Clinical Trial at Dana-Farber Cancer Institute advances groundbreaking research for breast cancer in men\, addressing a critical gap in oncology. This program explores tailored treatments\, improves understanding of male-specific disease patterns\, and paves the way for targeted\, life-saving therapies. \n11:30am – 11:45am\nBREAK \n11:45am – 12:30pm\nRobert Bard\, MD\nMedical Director of Bard Diagnostics\n“Image Guided Treatment of Male Breast Cancer Tumors” \nRevolutionizing male breast cancer care—image guidance pinpoints tumors with precision\, attacking cancer while protecting healthy tissue. This cutting-edge approach means fewer side effects\, greater accuracy\, and a powerful step toward personalized therapies that give men stronger outcomes and renewed hope for survival. \n12:30pm – 1:15pm\nCharlotte Bayala\nHost of The Cancer Caregiver Podcast\, Corporate Caregiver Wellness Program Designer\, Speaker\n“Before the Results: How to Stay Grounded When You Can’t Know What’s Coming” \nThis thoughtful tour offers caregivers guidance on staying grounded amid uncertainty. Drawing from the cancer journey\, it highlights resilience\, presence\, and self-care strategies—empowering caregivers to navigate the unknown with steadiness\, compassion\, and strength while supporting loved ones through unpredictable challenges. \n1:15pm – 2:00pm\nErling Donnelly\nVice President\, US Breast Cancer Franchise & Portfolio Marketing Lead\, Pfizer\n“Pfizer’s use of Real World Evidence to support the expansion of Ibrance for use in males and a look ahead.” \nIn today’s advancing cancer landscape\, Pfizer’s use of Real World Evidence (RWE) is reshaping access to Ibrance for men with breast cancer. Attendees will discover its regulatory impact\, clinical significance\, and the forward-looking role of RWE in transforming oncology therapies. \n2:00pm – 2:15pm\nBREAK \n2:15pm – 3:00pm\nDr. Leslie Waltke\nPhysical therapist with a clinical mastery in cancer rehabilitation\, Founder of the Waltke Cancer Rehabilitation Academy\n“The Male Breast Cancer Rehab Plan: easing side effects\, minimizing risks and getting strong again” \nThis presentation showcases how image-guided therapy is transforming male breast cancer care—bringing unmatched precision\, targeted tumor control\, and reduced side effects. Attendees will discover how this innovation drives personalized treatment\, improves survival\, and offers new hope for men battling breast cancer. \n3:00pm – 3:45pm\nDr. Barbara Bartlik\nIntegrative Psychiatrist\n“The Emotional Impact of Male Breast Cancer and its Treatment: Comprehensive Solutions to an Overlooked Problem” \nMale breast cancer carries profound emotional challenges that remain largely unrecognized in healthcare. Exploring the psychological toll of diagnosis and treatment\, this session highlights comprehensive strategies—mental health care\, family support\, and integrative approaches—to foster resilience\, healing\, and improved quality of life. \n\nOctober 25\, 2025\n10:00am – 10:45am\nFatima Cardoso\, MD\, MSc\, FESMO\nSenior Consultant\, Medical Oncology\nPresident ABC Global Alliance\n“Management of Advanced/Metastatic Breast Cancer in Male Patients” \nIn today’s evolving landscape of cancer care\, men with advanced or metastatic breast cancer face unique challenges often overshadowed by female-focused research. Dr. Fatima Cardoso delivers groundbreaking strategies in management\, therapies\, and compassionate care to transform outcomes and advance male-specific oncology. \n10:45am – 11:30am\nEllen Schupper\nExecutive Director – ABCD – After Breast Cancer Diagnosis\n“The Role of Male Breast Cancer Mentors” \nAmid growing recognition of male breast cancer\, mentorship emerges as a lifeline of hope. Ellen Schupper explores how trained peer mentors empower men with guidance\, emotional support\, and shared experience—bridging isolation and fostering resilience through every stage of diagnosis and survivorship. \n11:30am – 11:50am\nBREAK \n12:00pm – 12:45pm\nDon Dizon\, MD\nJane F. Desforges Chair in Hematology and Oncology and Professor of Medicine\, Tufts University\nChief\, Hematology and Oncology Service Line\, Tufts Medicine\n“Thriving and Palliative Care; What it is and is Not” \nIn an era redefining survivorship\, thriving with cancer requires clarity on palliative care’s true purpose. Dr. Don Dizon challenges misconceptions\, illustrating how palliative care empowers patients—enhancing quality of life\, dignity\, and resilience while advancing beyond outdated views of end-of-life treatment. \n12:25pm – 1:30pm\nBen Park\, MD\nBenjamin F. Byrd\, Jr. Chair in Oncology\nDirector\, Vanderbilt-Ingram Cancer Center\nProfessor of Medicine\, Vanderbilt University Medical Center\n“Circulating Tumor DNA in Early Stage Breast Cancer; Breast Friends Don’t Keep Secrets” \nAs precision medicine reshapes oncology\, circulating tumor DNA offers powerful insight into early-stage breast cancer. This session reveals how ctDNA testing uncovers hidden disease\, guides treatment decisions\, and transforms transparency in care—proving that breast friends don’t keep secrets when survival is at stake. \n1:30pm – 2:15pm\nAngela Mazza\, DO\nTriple board-certified in Endocrinology\, Diabetes and Metabolism\, Internal Medicine\, and Anti-aging and Regenerative Medicine\n“Hormones and Male Cancers” \nIn the evolving fight against men’s cancers\, hormones play a pivotal yet often misunderstood role. Dr. Angela Mazza unpacks the endocrine influences driving cancer risk and progression\, offering groundbreaking insights that bridge prevention\, precision treatment\, and regenerative approaches for improved outcomes. \n  \nWITH YOUR HOST\, CHERI AMBROSE\nFounder and CEO of the Male Breast Cancer Global Alliance (MBCGA) \nCheri Ambrose has become one of the world’s most influential voices in the fight against men’s cancers. A tireless advocate\, she has built an international consortium of survivors\, caregivers\, and medical professionals to confront the biases\, knowledge gaps\, and inequities surrounding male breast cancer. Her leadership has not only elevated the visibility of this rare disease but has also inspired research collaborations\, legislative progress\, and global educational campaigns that continue to save lives. In hosting this 2025 symposium\, Ms. Ambrose represents and unites the expertise of twelve distinguished speakers\, each bringing groundbreaking insights from oncology\, endocrinology\, rehabilitation\, imaging\, and survivorship care. Together\, they highlight the most pressing frontiers in male breast cancer: from early access to life-saving therapies and the use of circulating tumor DNA for precision detection\, to image-guided tumor treatment\, integrative rehab strategies\, and palliative care redefined as a pathway to thriving. By convening this gathering of global experts\, she continues to advance the Alliance’s core mission: education\, advocacy\, and the relentless pursuit of equity in cancer care.
URL:https://mbcglobalalliance.org/event/fall-2025-medical-summit/
ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2025/09/medsum-1-scaled.png
END:VEVENT
END:VCALENDAR